← All companies

TVRD

Tvardi Therapeutics, Inc.

TVRD Nasdaq Pharmaceutical Preparations EDGAR ↗

$2.02

-0.08 -3.81%

Key statistics

from XBRL data in SEC filings

Market cap

$19.0M

Revenue (TTM)

$7.57M

Net income (TTM)

-$15.4M

EPS (TTM)

$-0.27

P/E ratio

—

Dividend yield

—

Free cash flow

-$24.5M

Cash

$19.9M

Total assets

$25.8M

Gross margin

—

52-week range

$1.50 – $43.65

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure Jul 30, 2026 8-K Other events Jul 17, 2026 8-K Regulation FD disclosure Jul 7, 2026 8-K Shareholder vote results Jun 11, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Results of operations (earnings release) May 8, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Results of operations (earnings release) Mar 31, 2026 8-K Other events Mar 6, 2026 8-K Regulation FD disclosure Jan 16, 2026 8-K Director or officer change Dec 18, 2025 8-K Regulation FD disclosure Nov 19, 2025 8-K Results of operations (earnings release) Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Other events Oct 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Director or officer change Jul 14, 2025 8-K Other events Jun 9, 2025 8-K Regulation FD disclosure May 27, 2025 8-K Results of operations (earnings release); Changed accountants May 13, 2025 8-K/A Completed an acquisition or disposition May 13, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Modified rights of security holders; Change in control; Director or officer change; Amended charter or bylaws; Item 5.05; Item 5.06; Regulation FD disclosure; Other events Apr 15, 2025 8-K Regulation FD disclosure Apr 11, 2025 8-K Shareholder vote results; Other events Apr 1, 2025 8-K Other events Mar 24, 2025 10-K Fiscal year ended 2024-12-31 Mar 11, 2025 8-K Regulation FD disclosure Jan 21, 2025 8-K Other events Jan 17, 2025 8-K Amended charter or bylaws Dec 30, 2024 8-K/A FORM 8-K/A Dec 20, 2024 8-K Entered a material agreement; Change in control; Director or officer change; Other events Dec 18, 2024 8-K Delisting notice or listing-rule failure Nov 22, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Delisting notice or listing-rule failure Aug 1, 2024 8-K Exit or disposal costs Jun 18, 2024 8-K Regulation FD disclosure; Other events Jun 12, 2024 8-K Amended charter or bylaws; Shareholder vote results Jun 7, 2024